Unknown PHASE3 INTERVENTIONAL 2-arm NCT02785523

Clinical Trial on Ganoderma Spore Lipids Combined With Chemo in Patients With G.I. Cancers

Sponsor: Xiaonan Cui

Interventions Chemotherapy Ganoderma Spore Lipids Placebo

Updated 6 times since 2017 Last updated: May 24, 2016 Started: May 31, 2016 Primary completion: May 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02785523, this PHASE3 trial focuses on Gastrointestinal Neoplasms and remains ongoing. Sponsored by Xiaonan Cui, it has been updated 6 times since 2016, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Feb 2017 — Jun 2018 [monthly]

Recruiting PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE3

First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Xiaonan Cui

Data source: The First Affiliated Hospital of Dalian Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dalian, China